ClinicalTrials.gov record
Completed Phase 2 Interventional

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00002676

Public ClinicalTrials.gov record NCT00002676. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PHASE II TRIAL OF CHEMOTHERAPY PLUS RADIOTHERAPY FOR MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM NON-HODGKIN'S LYMPHOMA (PCNSL)

Study identification

NCT ID
NCT00002676
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
36 participants

Conditions and interventions

Conditions

Interventions

  • carmustine Drug
  • cyclophosphamide Drug
  • cytarabine Drug
  • dexamethasone Drug
  • doxorubicin hydrochloride Drug
  • low-LET cobalt-60 gamma ray therapy Radiation
  • low-LET photon therapy Radiation
  • methotrexate Drug
  • vincristine sulfate Drug

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 1995
Primary completion
Sep 30, 2006
Completion
Sep 30, 2006
Last update posted
Jul 13, 2016

1995 – 2006

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404
CCOP - Colorado Cancer Research Program, Inc. Denver Colorado 80209-5031
CCOP - Illinois Oncology Research Association Peoria Illinois 61602
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
CCOP - Wichita Wichita Kansas 67214-3882
CCOP - Ochsner New Orleans Louisiana 70121
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731
CCOP - Duluth Duluth Minnesota 55805
Mayo Clinic Cancer Center Rochester Minnesota 55905
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131
CCOP - Northern New Jersey Hackensack New Jersey 07601
Quain & Ramstad Clinic, P.C. Bismarck North Dakota 58501
Altru Health Systems Grand Forks North Dakota 58201
CCOP - Columbus Columbus Ohio 43206
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456
Rapid City Regional Hospital Rapid City South Dakota 57709
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57105-1080

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002676, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2016 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002676 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →